NASDAQ:MDSO - Medidata Solutions Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$68.64 +2.57 (+3.89 %)
(As of 01/16/2019 07:22 AM ET)
Previous Close$66.07
Today's Range$66.11 - $69.27
52-Week Range$59.60 - $88.87
Volume385,997 shs
Average Volume479,918 shs
Market Capitalization$4.04 billion
P/E Ratio80.75
Dividend YieldN/A
Beta1.32
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner and ongoing support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and CROs and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.

Receive MDSO News and Ratings via Email

Sign-up to receive the latest news and ratings for MDSO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:MDSO
CUSIP58471A10
Phone212-918-1800

Debt

Current Ratio2.52
Quick Ratio2.52

Price-To-Earnings

Sales & Book Value

Annual Sales$545.53 million
Price / Sales7.70
Cash Flow$1.6135 per share
Price / Cash Flow42.54
Book Value$8.51 per share
Price / Book8.07

Profitability

Net Income$44.38 million
Net Margins8.43%
Return on Assets5.69%

Miscellaneous

Employees1,680
Market Cap$4.04 billion
OptionableOptionable

Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions

What is Medidata Solutions' stock symbol?

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

How were Medidata Solutions' earnings last quarter?

Medidata Solutions Inc (NASDAQ:MDSO) announced its quarterly earnings results on Thursday, October, 18th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.06. The company had revenue of $163.41 million for the quarter, compared to the consensus estimate of $162.09 million. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. The company's revenue for the quarter was up 17.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.33 earnings per share. View Medidata Solutions' Earnings History.

When is Medidata Solutions' next earnings date?

Medidata Solutions is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for Medidata Solutions.

What guidance has Medidata Solutions issued on next quarter's earnings?

Medidata Solutions updated its FY 2018 earnings guidance on Thursday, October, 18th. The company provided earnings per share (EPS) guidance of $1.48-1.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.57. The company issued revenue guidance of $624-648 million, compared to the consensus revenue estimate of $636.64 million.

What price target have analysts set for MDSO?

10 brokerages have issued 12 month price targets for Medidata Solutions' shares. Their predictions range from $70.00 to $90.00. On average, they anticipate Medidata Solutions' stock price to reach $83.70 in the next twelve months. This suggests a possible upside of 21.9% from the stock's current price. View Analyst Price Targets for Medidata Solutions.

What is the consensus analysts' recommendation for Medidata Solutions?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions.

Has Medidata Solutions been receiving favorable news coverage?

News articles about MDSO stock have trended positive on Wednesday, according to InfoTrie. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medidata Solutions earned a daily sentiment score of 2.2 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days.

Who are some of Medidata Solutions' key competitors?

Who are Medidata Solutions' key executives?

Medidata Solutions' management team includes the folowing people:
  • Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 56)
  • Mr. Glen M. De Vries, Co-Founder, Pres & Director (Age 46)
  • Mr. Rouven Bergmann, CFO & Chief Accounting Officer (Age 45)
  • Mr. Michael I. Otner, Exec. VP, Gen. Counsel & Sec. (Age 47)
  • Mr. Michael Pray, Exec. VP of Sales (Age 52)

Who are Medidata Solutions' major shareholders?

Medidata Solutions' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Summit Creek Advisors LLC (0.23%), Retirement Systems of Alabama (0.18%) and KAMES CAPITAL plc (0.04%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De. View Institutional Ownership Trends for Medidata Solutions.

Which major investors are selling Medidata Solutions stock?

MDSO stock was sold by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc. Company insiders that have sold Medidata Solutions company stock in the last year include Lee Shapiro, Michael I Otner, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Insider Buying and Selling for Medidata Solutions.

Which major investors are buying Medidata Solutions stock?

MDSO stock was bought by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC and Retirement Systems of Alabama. View Insider Buying and Selling for Medidata Solutions.

How do I buy shares of Medidata Solutions?

Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medidata Solutions' stock price today?

One share of MDSO stock can currently be purchased for approximately $68.64.

How big of a company is Medidata Solutions?

Medidata Solutions has a market capitalization of $4.11 billion and generates $545.53 million in revenue each year. The company earns $44.38 million in net income (profit) each year or $0.85 on an earnings per share basis. Medidata Solutions employs 1,680 workers across the globe.

What is Medidata Solutions' official website?

The official website for Medidata Solutions is http://www.mdsol.com.

How can I contact Medidata Solutions?

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]


MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  430 (Vote Outperform)
Underperform Votes:  328 (Vote Underperform)
Total Votes:  758
MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel